FDA Releases Guidance for Review and Inspection of Premarket Approval Applications Under Bioresearch Monitoring Program

Summary

The Food and Drug Administration (FDA) has made available a new guidance document that outlines the review and inspection process for premarket approval applications under the Bioresearch Monitoring Program, aiming to improve the efficiency of the process for both applicants and the FDA.